Drug design

The rapidly growing area of drug design solely depends on the genomics, proteomics and structural information. The combination of combinatorial chemistry and structure-based design can lead to a successful drug designing. The structure-based drug design directs the discovery of a drug lead, which is not a drug product but, specifically, a compound with at least micro molar affinity for a target.


  • Protein flexibility and dynamics
  • Structure based drug design
  • Computer based drug design
  • De novo generation
  • Protein and ligand flexibility
  • Drug lead evaluation

Related Conference of Drug design

Drug design Conference Speakers